(Figure 1) Among the patients older than 70 years without a diagnosis of preoperative renal failure, therapy with angiotensin-converting enzyme (ACE) inhibitors, CPB duration, male gender and preoperative haematocrit <36% were significant risk factors for AKI (Table 5). This evidence concerns the gene ACE and kidney failure.